Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.60 |
| ▸ | DPP8 | Q6V1X1 | 5/20 | 0.54 |
| ▸ | DPP9 | Q86TI2 | 5/20 | 0.54 |
| ▸ | DPP7 | Q9UHL4 | 5/20 | 0.54 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.49 |
| ▸ | NOD1 | Q9Y239 | 7/20 | 0.49 |
| ▸ | DPP4 | P27487 | 2/20 | 0.49 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.48 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.48 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.48 |
| ▸ | TLR2 | O60603 | 1/20 | 0.45 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.44 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.44 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.44 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31256792 | 1.00 | FOLH1 (0.60) | FOLH1DPP8DPP9DPP7SLC6A5 | |
| SCHEMBL30099573 | 0.94 | FOLH1 (0.68) | FOLH1DPP8DPP9DPP7SLC6A5 | |
| SCHEMBL31635787 | 0.94 | FOLH1 (0.68) | FOLH1DPP8DPP9DPP7SLC6A5 | |
| SCHEMBL30099516 | 0.94 | FOLH1 (0.68) | FOLH1DPP8DPP9DPP7SLC6A5 | |
| SCHEMBL31635790 | 0.94 | FOLH1 (0.68) | FOLH1DPP8DPP9DPP7SLC6A5 | |
| SCHEMBL30099724 | 0.94 | FOLH1 (0.68) | FOLH1DPP8DPP9DPP7SLC6A5 | |
| SCHEMBL31635789 | 0.94 | FOLH1 (0.68) | FOLH1DPP8DPP9DPP7SLC6A5 | |
| SCHEMBL31635788 | 0.94 | FOLH1 (0.68) | FOLH1DPP8DPP9DPP7SLC6A5 | |
| SCHEMBL7166207 | 0.94 | FOLH1 (0.68) | FOLH1DPP8DPP9DPP7SLC6A5 | |
| SCHEMBL29533698 | 0.94 | FOLH1 (0.68) | FOLH1DPP8DPP9DPP7SLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250222122-A1 | PSMA TARGETED CONJUGATE COMPOUNDS AND USES THEREOF | UNIV CASE WESTERN RESERVE (US) | 2025-07-10 | — | — | US | disclosed |
| US-12144863-B2 | PSMA targeted conjugate compounds and uses thereof | CASE WESTERN RESERVE UNIVERSITY (US) | 2024-11-19 | — | — | US | disclosed |
| US-11975074-B2 | Photodynamic therapy composition | CASE WESTERN RESERVE UNIVERSITY (US) | 2024-05-07 | — | — | US | disclosed |
| US-20220378926-A1 | PSMA TARGETED CONJUGATE COMPOUNDS AND USES THEREOF | UNIV CASE WESTERN RESERVE (US) | 2022-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12144863-B2 | PSMA targeted conjugate compounds and uses thereof | FOLH1, PSMA2, PSMA6 | FOLH1 1/4885DPP8 128/4885DPP9 51/4885 |
| US-20220378926-A1 | PSMA TARGETED CONJUGATE COMPOUNDS AND USES THEREOF | FOLH1, PSMA2, PSMA6 | FOLH1 1/4885DPP8 128/4885DPP9 51/4885 |
| US-11975074-B2 | Photodynamic therapy composition | PSMA1, PSMA7, FOLH1 | FOLH1 3/4885DPP8 1689/4885DPP9 335/4885 |
| US-20250222122-A1 | PSMA TARGETED CONJUGATE COMPOUNDS AND USES THEREOF | FOLH1, PSMA2, PSMA6 | FOLH1 1/4885DPP8 128/4885DPP9 51/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.